Manhattan Medical Research

New York, New York 10016

0 studies enrolling now · 32 studies all time

What they study most

BPH (Benign Prostatic Hyperplasia), Benign Prostatic Hyperplasia, Bladder Cancer, Cancer of Prostate, Carcinoma in Situ of Bladder, Diabetes Mellitus, Type 2, Endometrial Related Pain, Erectile Dysfunction, Incontinence, Urinary, Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention, Lower Urinary Tract Symptom, Lower Urinary Tract Symptoms (LUTS)

Studies at this site

• A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years — Completed
• Butterfly Pivotal Study — Running, not enrolling
• A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer — Running, not enrolling
• A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC) — Completed
• Safety and Efficacy Study of MT-2990 in Women With Endometriosis — Completed
• Pivotal Study of eCoin for Overactive Bladder With Urgency Urinary Incontinence — Completed
• Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness — Completed
• Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness — Completed
• PK Sub-Study of QUILT-3.032 (CA ALT-803-01-16) and of QUILT-2.005 (CA ALT-803-01-14) — Stopped early
• A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer — Stopped early
• A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer — Completed
• A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin — Completed
• Clinical Evaluation of the 'ExoDx Prostate IntelliScore' (EPI) — Completed
• IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE) — Completed
• A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes — Completed
• A Study of LY900014 in Participants With Type 1 Diabetes — Completed
• Safety and Efficacy Study for the Treatment of BPH (Enlarged Prostate) — Completed
• A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diabetes — Completed
• Evaluation of an Alternative Injection Paradigm for OnabotulinumtoxinA (BOTOX®) in the Treatment of Overactive Bladder in Patients With Urinary Incontinence — Completed
• IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT), Patient Reported Outcomes and Safety in Men With Premature Ejaculation (PE) — Completed
• A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus — Completed
• 18F Fluciclovine (FACBC) PET/CT in Patients With Rising PSA After Initial Prostate Cancer Treatment — Completed
• A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02). — Completed
• Study of the Safety and Tolerability of Switching to ITCA 650 in Patients With Type 2 Diabetes Receiving Liraglutide — Completed
• A Safety and Efficacy Study of OnabotulinumtoxinA in Premature Ejaculation — Stopped early
• Dornier Aries 2 Extracorporeal Shock Wave Device for the Treatment of Mild Erectile Dysfunction (ED) — Stopped early
• A Study of LY2409021 on Blood Pressure and Pulse Rate in Participants With Type 2 Diabetes Mellitus — Completed
• Study of Intra-articular Injections vs Placebo in Patients With Pain From Osteoarthritis of the Knee — Completed
• OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder — Completed
• A Study of LY2963016 Compared to LANTUS® in Adult Participants With Type 2 Diabetes Mellitus — Completed
• Phase 2a Topical Sildenafil Proof-of-Concept Study in Men With Mild to Moderate ED — Completed
• Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer — Completed